CIM
MDT icon

Cambria Investment Management’s Medtronic MDT Stock Holding History

Cambria Investment Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$552K Buy
6,370
+3,236
+103% +$310K 0.03% 416
2025
Q4 		$301K Buy
+3,134
New +$304K 0.02% 503

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cambria Investment Management's MDT Position: Q1 2026 in Review

Cambria Investment Management increased its Medtronic (MDT) stake by 103% in Q1 2026, buying an estimated $310K and bringing the position to 6,370 shares worth $552K. The position accounts for 0.03% of the portfolio, ranked #416.

Cambria Investment Management first reported a position in MDT in Q4 2025 and has held it in 2 quarters since. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Cambria Investment Management held 6,370 shares of Medtronic worth $552K as of Q1 2026.
  • Cambria Investment Management bought 3,236 Medtronic shares in Q1 2026, an estimated $310K.
  • Medtronic made up 0.03% of Cambria Investment Management's portfolio in Q1 2026, its #416 holding.
  • Cambria Investment Management first reported a position in Medtronic in Q4 2025 and has held it in 2 quarters since.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Cambria Investment Management's 13F filing for Q1 2026, filed 15 May 2026.